Vericel (VCEL) Non Operating Income (2010 - 2026)
Vericel (VCEL) reported Non Operating Income of $1.8 million for Q1 2026, up 13.97% on a YoY basis from $1.5 million in Q1 2025, and up 4.45% sequentially from $1.7 million in Q4 2025.
Vericel (VCEL) Non Operating Income (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Non Operating Income data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 13.97% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 10.35% YoY), and the FY2025 full-year result was $6.3 million, up 5.71% from the prior year.
- Non Operating Income advanced to $1.8 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.8 million in Q1 2026 to a low of $119000.0 in Q2 2022.
- A 5-year average of $1.1 million and a median of $1.4 million in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 693.33% in 2022 and declined 3.5% in 2025, its largest moves.
- Tracing VCEL's Non Operating Income over 5 years: stood at $537000.0 in 2022, then jumped by 153.63% to $1.4 million in 2023, then advanced by 8.37% to $1.5 million in 2024, then grew by 14.3% to $1.7 million in 2025, then gained by 4.45% to $1.8 million in 2026.
- Business Quant data shows VCEL's Non Operating Income at $1.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 941,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | 537,000.00 |
| Sep 30, 2022 | 232,000.00 |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 68,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 15,000.00 |